GLP Peptide
From $89.99
Advanced triple-agonist GLP receptor research compound. Lyophilized powder, ≥99% purity verified via HPLC and mass spectrometry. Certificate of Analysis included with every order. For research and laboratory use only.
GLP3-RT is a synthetic triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor agonist represents a significant advancement in metabolic research, enabling investigators to study the synergistic effects of combined incretin pathway activation in laboratory settings.
Each vial contains pharmaceutical-grade lyophilized GLP3-RT powder, sealed under sterile conditions for maximum stability and shelf life. The compound is independently verified to ≥99% purity by third-party HPLC and mass spectrometry analysis.
Available in 10mg, 20mg, 30mg, and 40mg configurations to support a range of in-vitro research protocols.
| Compound | GLP3-RT (Retatrutide analog) |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder |
| Available Sizes | 10mg, 20mg, 30mg, 40mg |
| Storage | Store at -20°C. Protect from light. |
| Reconstitution | Bacteriostatic water or sterile saline |
| Molecular Target | GLP-1R / GIPR / GCGR triple agonist |
| Testing | HPLC, Mass Spectrometry, Endotoxin |
| COA | Included with every order |
GLP3-RT has been the subject of extensive preclinical research investigating multi-receptor agonism in metabolic pathways. Key areas of published in-vitro and animal model research include:
All research references are available upon request. This compound is sold exclusively for in-vitro and laboratory research use.
All sales are final once shipped. Refunds available only if order hasn't shipped or wrong product received — contact us within 7 days.
GLP3-RT
$89.99
All products are for research and laboratory use only. Not for human consumption.
